Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongli Ji

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 25, 2021
Heme Oxygenase-1 in Macrophages Impairs the Perfusion Recovery After Hindlimb Ischemia by Suppressing Autolysosome-Dependent Degradation of NLRP3Yuankun Ma, Liangliang Jia, Yidong Wang, et al.
Molecular Nutrition & Food Research|March 6, 2023
Single-Cell Transcriptomics Reveals the Difference of Aortic Atherosclerosis Response to Phytosterols and Oxidation Products of SterolsZhangtie Wang, Mengmeng Wang, Yunrui Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005Yongli Ji, Cathryn Rankin, Steven Grunberg, et al.
Nature Communications|August 27, 2025
Disassembly of chiral hydrogen-bonded frameworks into single-unit organometallic helices for enantioselective amyloid inhibitionYongli Ji, Caoyu Yang, Yutong Ye, et al.
Materials Science & Engineering. C, Materials for Biological Applications|May 16, 2020
Cell-modified bioprinted microspheres for vascular regenerationJian Shen, Yongli Ji, Mingjun Xie, et al.
Cancer Discovery|November 2, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA MutationsAndreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, et al.
Cancer Discovery|November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from HyperinsulinemiaAndreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 25, 2021
Heme Oxygenase-1 in Macrophages Impairs the Perfusion Recovery After Hindlimb Ischemia by Suppressing Autolysosome-Dependent Degradation of NLRP3Yuankun Ma, Liangliang Jia, Yidong Wang, et al.
Molecular Nutrition & Food Research|March 6, 2023
Single-Cell Transcriptomics Reveals the Difference of Aortic Atherosclerosis Response to Phytosterols and Oxidation Products of SterolsZhangtie Wang, Mengmeng Wang, Yunrui Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005Yongli Ji, Cathryn Rankin, Steven Grunberg, et al.
Nature Communications|August 27, 2025
Disassembly of chiral hydrogen-bonded frameworks into single-unit organometallic helices for enantioselective amyloid inhibitionYongli Ji, Caoyu Yang, Yutong Ye, et al.
Materials Science & Engineering. C, Materials for Biological Applications|May 16, 2020
Cell-modified bioprinted microspheres for vascular regenerationJian Shen, Yongli Ji, Mingjun Xie, et al.
Cancer Discovery|November 2, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA MutationsAndreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, et al.
Cancer Discovery|November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from HyperinsulinemiaAndreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Pageof 3